Olivier Danos

Regenxbio

Chief Scientific Officer

Overview

Olivier Danos made an average of $1.7M in compensation at Regenxbio between 2017 and 2018.

Annual data

2018

In 2018, Olivier Danos earned a total compensation of $1.6M as Chief Scientific Officer at Regenxbio.

Ranking5,545 out of 10,934
Percentile49.3%

Olivier Danos' 2018 compensation ranked 5,545th out of 10,934 executive pay records tracked by us this year.

Danos earned more than 49.3% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking630 out of 1,246
Percentile49.4%

In the industry group of Drugs, Danos' pay ranked 630th out of 1,246 executive pay records tracked by us in 2018.

Danos earned more than 49.4% of executives in this group.

Non-Equity Incentive Plan$207,568
Option Awards$982,739
Salary$409,000
Other$14,462
Total$1,613,769

Danos received $982.7K in option awards, which accounts for 60.90% of total compensation.

Danos also received $207.6K in non-equity incentive plan, $409K in salary and $14.5K in other compensation.

2017

In 2017, Olivier Danos earned a total compensation of $1.9M as Chief Scientific Officer at Regenxbio.

Ranking5,507 out of 13,778
Percentile60.0%

Olivier Danos' 2017 compensation ranked 5,507th out of 13,778 executive pay records tracked by us this year.

Danos earned more than 60.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking474 out of 1,566
Percentile69.7%

In the industry group of Drugs, Danos' pay ranked 474th out of 1,566 executive pay records tracked by us in 2017.

Danos earned more than 69.7% of executives in this group.

Bonus$50,000
Non-Equity Incentive Plan$108,938
Option Awards$1,390,000
Salary$307,692
Other$15,525
Total$1,872,155

Danos received $1.4M in option awards, which accounts for 74.25% of total compensation.

Danos also received $50K in bonus, $108.9K in non-equity incentive plan, $307.7K in salary and $15.5K in other compensation.